The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world patient-reported outcomes in stage II/III rectal cancer in the Netherlands.
 
Renee Lunenberg
No Relationships to Disclose
 
Frederieke van der Baan
Research Funding - Personal Genomic Diagnostics
 
Ingrid Franken
Research Funding - DoMore Diagnostics (Inst)
 
Femke Sijtsma
No Relationships to Disclose
 
Geraldine Vink
Research Funding - Bayer (Inst); BMS Netherlands (Inst); Delfi Diagnostics (Inst); Merck (Inst); Natera (Inst); Nordic Bioscience (Inst); Personal Genome Diagnostics (Inst); Pierre Fabre (Inst); SERVIER (Inst)
 
Marloes Elferink
No Relationships to Disclose
 
Susan Boklage
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Martijn Intven
Research Funding - Dutch Cancer Society
Other Relationship - Employee of UMC Utrecht; Role within the Dutch Society for Radiotherapy and Oncology
 
Jamie Garside
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Miriam Koopman
Honoraria - Bristol-Myers Squibb (Inst); Nordic Bioscience (Inst); Servier (Inst)
Research Funding - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Nordic Bioscience (Inst); Personal Genome Diagnostics (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst); Servier (Inst); Sirtex Medical (Inst)
Travel, Accommodations, Expenses - Congress Care-Dutch Oncology Society (NVMO)
(OPTIONAL) Uncompensated Relationships - Involvement in several clinical trials as a principal investigator or coinvestigator in colorectal cancer; Principal investigator of the Prospective Dutch CRC cohort (PLCRC)
 
Rob van Wuijtswinkel
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Jeanine Roodhart
No Relationships to Disclose